These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces. Naik NH; Russo TA Clin Infect Dis; 2009 Dec; 49(11):1729-32. PubMed ID: 19886792 [TBL] [Abstract][Full Text] [Related]
5. Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant? Junquera L; Gallego L J Oral Maxillofac Surg; 2008 Jul; 66(7):1516-7. PubMed ID: 18571043 [No Abstract] [Full Text] [Related]
6. Intravenous bisphosphonate treatment and osteonecrosis of the jaw in patients with cancer: wide CIs, Yule-Simpson and King Kong effects, and no therapeutic outcomes. Abraham I J Clin Oncol; 2010 Mar; 28(9):e143-4; author reply e145-7. PubMed ID: 20159796 [No Abstract] [Full Text] [Related]
7. Bisphosphonate treatment as a cause of jaw osteonecrosis. Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221 [No Abstract] [Full Text] [Related]
8. Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder. Dannemann C; Grätz KW; Riener MO; Zwahlen RA Bone; 2007 Apr; 40(4):828-34. PubMed ID: 17236837 [TBL] [Abstract][Full Text] [Related]
9. Letter to the editor. Ehrmann EH Aust Endod J; 2010 Aug; 36(2):96. PubMed ID: 20666758 [No Abstract] [Full Text] [Related]
10. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. Marx RE; Sawatari Y; Fortin M; Broumand V J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172 [TBL] [Abstract][Full Text] [Related]
11. Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series. Ferlito S; Liardo C; Puzzo S Minerva Stomatol; 2010; 59(11-12):593-601. PubMed ID: 21217623 [TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaw. Reilly MM; Moore S Oncology (Williston Park); 2008 Feb; 22(2 Suppl Nurse Ed):39-41. PubMed ID: 18431898 [No Abstract] [Full Text] [Related]
13. Osteonecrosis of the jaw associated with bisphosphonate therapy. Wirth SM; Lawson AP; Sutphin SD; Adams VR Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241 [No Abstract] [Full Text] [Related]
14. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children? Brown JJ; Ramalingam L; Zacharin MR Clin Endocrinol (Oxf); 2008 Jun; 68(6):863-7. PubMed ID: 18221397 [TBL] [Abstract][Full Text] [Related]
15. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Bagan JV; Jimenez Y; Murillo J; Hernandez S; Poveda R; Sanchis JM; Diaz JM; Scully C Oral Oncol; 2006 Mar; 42(3):327-9. PubMed ID: 16275156 [No Abstract] [Full Text] [Related]
16. Bisphosphonate-related osteonecrosis of the jaw. Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174 [TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients. Kyrgidis A; Vahtsevanos K; Koloutsos G; Andreadis C; Boukovinas I; Teleioudis Z; Patrikidou A; Triaridis S J Clin Oncol; 2008 Oct; 26(28):4634-8. PubMed ID: 18574158 [TBL] [Abstract][Full Text] [Related]
18. Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment. Bamias A; Terpos E; Dimopoulos MA Onkologie; 2010; 33(6):288-9. PubMed ID: 20523090 [No Abstract] [Full Text] [Related]
19. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants. Lazarovici TS; Yahalom R; Taicher S; Schwartz-Arad D; Peleg O; Yarom N J Oral Maxillofac Surg; 2010 Apr; 68(4):790-6. PubMed ID: 20307764 [TBL] [Abstract][Full Text] [Related]
20. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates. Kraj M; Pogłód R; Maj S; Owczarska K Acta Pol Pharm; 2006; 63(5):450-2. PubMed ID: 17357613 [No Abstract] [Full Text] [Related] [Next] [New Search]